Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Periodontal Res ; 49(5): 652-9, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25340204

RESUMEN

BACKGROUND AND OBJECTIVE: Green tea extract exerts a variety of biological effects, including anti-inflammatory activities. However, there has been no report on the effect of green tea extract on loss of attachment, which is an important characteristic of periodontitis. Here, we examined the inhibitory effects of green tea extract on the onset of periodontitis in a rat model. MATERIAL AND METHODS: Rats were immunized intraperitoneally with Escherichia coli lipopolysaccharide (LPS). The LPS group (n = 12) received a topical application of LPS onto the palatal gingival sulcus every 24 h. The green tea extract group (n = 12) received a topical application of LPS mixed with green tea extract, sunphenon BG, every 24 h. The phosphate-buffered saline (PBS) group (n = 6) received a topical application of PBS every 24 h. The levels of anti-LPS immunoglobulin G (IgG) in serum were determined using ELISA. Rats in the LPS and green tea extract groups were killed after the 10th and 20th applications. Rats in the PBS group were killed after the 20th application. Loss of attachment, level of alveolar bone and inflammatory cell infiltration were investigated histopathologically and histometrically. RANKL-positive cells and the formation of immune complexes were evaluated immunohistologically. RESULTS: There was no significant difference in the serum levels of anti-LPS IgG between the LPS group and the green tea extract group. In contrast, loss of attachment, level of alveolar bone, inflammatory cell infiltration and RANKL expression in the green tea extract group were significantly decreased compared with those in the LPS group. CONCLUSION: These findings demonstrate that green tea extract suppresses the onset of loss of attachment and alveolar bone resorption in a rat model of experimental periodontitis.


Asunto(s)
Antiinflamatorios/uso terapéutico , Camellia sinensis , Periodontitis/prevención & control , Fenoles/uso terapéutico , Extractos Vegetales/uso terapéutico , Pérdida de Hueso Alveolar/patología , Pérdida de Hueso Alveolar/prevención & control , Animales , Anticuerpos Antibacterianos/sangre , Complejo Antígeno-Anticuerpo/análisis , Tejido Conectivo/patología , Modelos Animales de Enfermedad , Inserción Epitelial/patología , Escherichia coli/inmunología , Inmunización , Inmunoglobulina G/sangre , Lipopolisacáridos/inmunología , Masculino , Osteoclastos/patología , Pérdida de la Inserción Periodontal/patología , Pérdida de la Inserción Periodontal/prevención & control , Periodontitis/patología , Fitoterapia , Ligando RANK/análisis , Ratas , Ratas Endogámicas Lew
2.
J Periodontal Res ; 45(1): 23-30, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19602116

RESUMEN

BACKGROUND AND OBJECTIVE: Bone resorption is positively regulated by receptor activator of nuclear factor-kappaB ligand (RANKL). Pro-inflammatory cytokines, such as interleukin (IL)-1beta, promote RANKL expression by stromal cells and osteoblasts. Green tea catechin (GTC) has beneficial effects on human health and has been reported to inhibit osteoclast formation in an in vitro co-culture system. However, there has been no investigation of the effect of GTC on periodontal bone resorption in vivo. We therefore investigated whether GTC has an inhibitory effect on lipopolysaccharide (LPS)-induced bone resorption. MATERIAL AND METHODS: Escherichia coli (E. coli) LPS or LPS with GTC was injected a total of 10 times, once every 48 h, into the gingivae of BALB/c mice. Another group of mice, housed with free access to water containing GTC throughout the experimental period, were also injected with LPS in a similar manner. RESULTS: The alveolar bone resorption and IL-1beta expression induced by LPS in gingival tissue were significantly decreased by injection or oral administration of GTC. Furthermore, when GTC was added to the medium, decreased responses to LPS were observed in CD14-expressing Chinese hamster ovary (CHO) reporter cells, which express CD25 through LPS-induced nuclear factor-kappaB (NF-kappaB) activation. These findings demonstrated that GTC inhibits nuclear translocation of NF-kappaB activated by LPS. In addition, osteoclasts were generated from mouse bone marrow macrophages cultured in a medium containing RANKL and macrophage colony-stimulating factor with or without GTC. The number of osteoclasts was decreased in dose-dependent manner when GTC was added to the culture medium. CONCLUSION: These results suggest that GTC suppresses LPS-induced bone resorption by inhibiting IL-1beta production or by directly inhibiting osteoclastogenesis.


Asunto(s)
Pérdida de Hueso Alveolar/prevención & control , Antioxidantes/uso terapéutico , Catequina/uso terapéutico , Escherichia coli , Lipopolisacáridos/efectos adversos , Animales , Antioxidantes/administración & dosificación , Antioxidantes/farmacología , Células de la Médula Ósea/efectos de los fármacos , Células CHO , Catequina/administración & dosificación , Catequina/análogos & derivados , Catequina/farmacología , Recuento de Células , Núcleo Celular/efectos de los fármacos , Células Cultivadas , Cricetinae , Cricetulus , Relación Dosis-Respuesta a Droga , Interleucina-1beta/efectos de los fármacos , Subunidad alfa del Receptor de Interleucina-2/efectos de los fármacos , Receptores de Lipopolisacáridos/efectos de los fármacos , Factor Estimulante de Colonias de Macrófagos/farmacología , Macrófagos/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos BALB C , FN-kappa B/efectos de los fármacos , Osteoclastos/efectos de los fármacos , Osteoclastos/patología , Ligando RANK/farmacología ,
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA